Bionomics Limited - Articles and news items

Bionomics initiates Phase II clinical study of BNC210 for the treatment of anxiety and depression

Industry news / 22 April 2015 / Victoria White

Bionomics has initiated a Phase II clinical study of BNC210, the Company’s drug candidate in development for the treatment of anxiety and depression…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+